DMH4

Names

[ Name ]:
DMH4

[Synonym ]:
6-{4-[2-(4-Morpholinyl)ethoxy]phenyl}-3-phenylpyrazolo[1,5-a]pyrimidine
Pyrazolo[1,5-a]pyrimidine, 6-[4-[2-(4-morpholinyl)ethoxy]phenyl]-3-phenyl-
dmh4
6-{4-[2-(morpholin-4-yl)ethoxy]phenyl}-3-phenylpyrazolo[1,5-a]pyrimidine

Biological Activity

[Description]:

DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 µM[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> VEGFR

[Target]

VEGFR2:0.16 μM (IC50)

[References]

[1]. Hao J, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245-53.

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Molecular Formula ]:
C₂₄H₂₄N₄O₂

[ Molecular Weight ]:
400.473

[ Exact Mass ]:
400.189911

[ PSA ]:
51.89000

[ LogP ]:
2.12

[ Index of Refraction ]:
1.653

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ RIDADR ]:
NONH for all modes of transport

Articles

Peptide Lv augments L-type voltage-gated calcium channels through vascular endothelial growth factor receptor 2 (VEGFR2) signaling.

Biochim. Biophys. Acta 1853(5) , 1154-64, (2015)

We previously identified peptide Lv, a novel bioactive peptide that enhances the activity of L-type voltage-gated calcium channels (L-VGCCs) in cone photoreceptors. In this study, we verified that pep...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.